Skip to Content

Equetro Shire Pharmaceuticals Group plc - Treatment for Bipolar Disorder

Equetro, previously known as SPD417, is indicated for the treatment of acute manic and mixed episodes associated with Bipolar I Disorder. Equetro will be available for prescribing in the US in the first quarter of 2005.

Posted: December 2004

Equetro (carbamazepine) FDA Approval History